Lv1
18 积分 2025-08-06 加入
Phase I study of BMS-663513, a fully human anti-CD137 agonist monoclonal antibody, in patients (pts) with advanced cancer (CA)
4小时前
求助中
Improving target cell specificity using a novel monovalent bispecific IgG design
1个月前
已完结
Clinical responses to SYNC-T therapy: In situ personalized cancer vaccination with intratumoral immunotherapy in patients with metastatic castration-resistant prostate cancer (mCRPC)
1个月前
已完结
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
2个月前
已完结
4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models
2个月前
已关闭
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
2个月前
已完结
Differential Receptor Subunit Affinities of Type I Interferons Govern Differential Signal Activation
2个月前
已完结
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
2个月前
已完结
1078P Randomised phase II study of ubamatamab ± cemiplimab in patients (pts) with platinum-resistant ovarian cancer (OC)
3个月前
已关闭
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
3个月前
已完结
皖公网安备34019202002308
